Vasopressors in Trauma Management Explained

Oct 1, 2024

Lecture on Vasopressors in Trauma

Introduction

  • Speaker: Dennis Kim
  • Event: Recess X 2022
  • Topic: Controversial use of vasopressors in trauma
  • Duration: 10-12 minutes
  • No financial disclosures

Lecture Outline

  1. Vasopressors as a 'Never Event'
  2. Rationale for Their Use
  3. Literature Review
  4. Concluding Points

Vasopressors as a 'Never Event'

  • Question: "Never have I ever administered vasopressors to a trauma patient?"
  • Common Use Cases:
    • Spinal cord injuries (e.g., cervical spinal cord injury with neurogenic shock)
    • Prolonged pre-hospital transport times
    • Post-intubation hypotension

Rationale for Use

  • Arguments for Vasopressors:
    • Excessive fluid resuscitation can lead to complications like:
      • Abdominal compartment syndrome
      • ARDS
      • Cardiac and pulmonary dysfunction
      • Inflammation and coagulopathy
    • Volume sparing resuscitation using vasopressors may reduce morbidity
    • Hormonal deficiencies in hemorrhagic shock (e.g., vasopressin) leading to catecholamine resistance
    • Shunting blood to critical organs and assisting with hemostasis

Literature Review

  • Retrospective Reviews:
    • Sperian et al. Study:
      • Early vasopressor use linked to higher mortality but involved severely injured patients
      • Phenylephrine, norepi, and dopamine associated with increased mortality
      • Volume status didn’t impact mortality significantly
    • Avert Trial (2019):
      • Studied low-dose AVP supplementation
      • Decreased transfusion requirements

Key Findings

  • Challenges in Studies:
    • Selection bias and unequal baseline demographics
  • Observations:
    • Early vasopressor use often linked to death
    • Vasopressors may be markers of injury severity rather than cause of mortality

Take-home Points

  • Literature Insights:
    • Predominantly observational studies
    • Early vasopressor use associated with adverse outcomes
  • Primary Focus:
    • Identify and stop bleeding
  • Vasopressors Post-Bleeding Control:
    • Low-dose vasopressors, particularly vasopressin, may be reasonable after bleeding control

Conclusion

  • Ongoing Questions:
    • Definition of 'early' intervention
    • Impact on elderly and brain-injured patients
    • Variability in vasopressor effects
  • Summary:
    • Vasopressors are not always harmful but should be considered in context
    • Emphasize bleeding control and injury severity assessment.

Notes based on Dennis Kim's lecture at Recess X 2022.

[Music] was playing during transitions.